RecruitingNCT04959097
Retinoblastoma Patient Clinical Database and Tissue Repository
Sponsor
Children's Hospital Los Angeles
Enrollment
800 participants
Start Date
Jan 1, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed. Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.
Eligibility
Min Age: 0 YearsMax Age: 18 Years
Inclusion Criteria1
- All patients, age 0 days to 18 years, with a diagnosis unilateral or bilateral retinoblastoma (RB) seen at CHLA (Children's Hospital Los Angeles).
Exclusion Criteria1
- Patients referred for second opinions only and not treated at CHLA for any reason.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04959097
Related Trials
Familial Investigations of Childhood Cancer Predisposition
NCT030502681 location
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
NCT011093945 locations
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
NCT035463871 location
Retinoblastoma Phase II Expanded Access Clinical Trial
NCT066796342 locations
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
NCT067251731 location